Prostate cancer screening in high-risk men: African American Hereditary Prostate Cancer Study Network

Cancer

Volumn 106, Issue 4, 2006, Pages 796-803

  Weinrich, Sally P ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

African American men; Health disparities; Hereditary prostate cancer; Prostate cancer screening

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CANCER SCREENING; CAUCASIAN; COHORT ANALYSIS; DECISION MAKING; DIGITAL RECTAL EXAMINATION; FAMILIAL CANCER; FAMILY HISTORY; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER;

ADULT; AFRICAN AMERICANS; AGE FACTORS; AGED; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; HEALTH SURVEYS; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PHYSICAL EXAMINATION; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RECTUM; RISK FACTORS;

EID: 32544438473     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.21674     Document Type: Article

References (46)

1. American Cancer Society. Cancer Facts and Figures 2004. Atlanta, GA: American Cancer Society, 2004.
2. Clegg LXP, Li FPM, Hankey BFS, Chu KP, Edwards BKP. Cancer survival among US whites and minorities: a SEER (surveillance, epidemiology, and end results) program population-based study. Arch Intern Med. 2002;162:1985-1993.
3. Zeigler-Johnson C. CYP3A4: a potential prostate cancer risk factor for high-risk groups. Clin J Oncol Nurs. 2001;5:153-154.
4. Powell IJ, Meyskens FL Jr. African American men and hereditary/familial prostate cancer: intermediate-risk populations for chemoprevention trials. Urology. 2001;57(Suppl): 81.
5. Powell IJ. Prostate cancer in the African American: is this a different disease? [review]. Semin Urol Oncol. 1998;16:221-226.
6. Cunningham GR, Ashton CM, Annegers JF, Souchek J, Klima M, Miles B. Familial aggregation of prostate cancer in African-Americans and white Americans. Prostate. 2003;56:256-262.
7. Narain V, Cher ML, Wood DPJ. Prostate cancer diagnosis, staging and survival. Cancer Metastasis Rev. 2002;21:17-27.
8. American Cancer Society. Cancer Facts Figures 2003. New York: American Cancer Society, 2003.
9. Bratt O, Damber JE, Emanuelsson M, et al. Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancer. Eur J Cancer. 2000;36:235-241.
10. Zeegers MP, Jellema A, Ostrer H. Empiric risk of prostate carcinoma for relatives of patients with prostate carcinoma: a meta-analysis. Cancer. 2003;97:1894-1903.
11. Cooney KA. Hereditary prostate cancer in African-American families [review]. Semin Urol Oncol. 1998;16:202-206.
12. Cotter MP, Gern RW, Ho GY, Chang RY, Burk RD. Role of family history and ethnicity on the mode and age of prostate cancer presentation. Prostate. 2002;50:216-221.
13. Grumet SC, Bruner DW. The identification and screening of men at high risk for developing prostate cancer [review]. Urol Nurs. 2000;20:15-18.
14. Makinen T, Tammela TL, Stenman UH, et al. Family history and prostate cancer screening with prostate-specific antigen. J Clin Oncol. 1920;2658-2663.
15. Virtanen A, Gomari M, Kranse R, Stenman UH. Estimation of prostate cancer probability by logistic regression: free and total prostate-specific antigen, digital rectal examination, and heredity are significant variables. Clin Chem. 1999;45:987-994.
16. Catalona WJ, Antenor JA, Roehl KA, Moul JW. Screening for prostate cancer in high risk populations. J Urol. 2002;168: 1980-1983.
17. Makinen T, Tammela TL, Stenman UH, et al. Family history and prostate cancer screening with prostate-specific antigen. J Clin Oncol. 2002;20:2658-2663.
18. Carter BS, Beaty TH, Steinberg GD, Childs B, Walsh PC. Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci U S A. 1992;89:3367-3371.
19. Cooney KA, McCarthy JD, Lange E, et al. Prostate cancer susceptibility locus on chromosome 1q: a confirmatory study [comment]. J Natl Cancer Inst. 1997;89:955-959.
20. Myers RE. African American men, prostate cancer early detection examination use, and informed decision-making. Semin Oncol. 1999;26:375-381.
21. Powell IJ, Heilbrun L, Littrup PL, Franklin A, Parzuchowski MS, Gelfand D. Outcome of African American men screened for prostate cancer: the Detroit Education and Early Detection Study. J Urol. 1997;158:146-149.
22. Powell IJ, Carpten J, Dunston G, et al. African-American heredity prostate cancer study: a model for genetic research. J Natl Med Assoc. 2001;93(Suppl):28S.
23. Robinson SB, Ashley M, Haynes MA. Attitude of African-Americans regarding prostate cancer clinical trials. J Community Health. 1996;21:77-87.
24. Weinrich SP, Boyd MD, Bradford D, Mossa MS, Weinrich M. Recruitment of African Americans into prostate cancer screening. Cancer Pract. 1998;6:23-30.
25. Eyre HJ, Feldman GE. Status report on prostate cancer in African Americans: a national blueprint for action. CA Cancer J Clin. 1998;48:315-319.
26. Stone BA. Prostate cancer early detection in African-American men: a priority for the 21st century. J Natl Med Assoc. 1998;90(Suppl):7.
27. Donini-Lenhoff FG, Hedrick HL. Increasing awareness and implementation of cultural competence principles in health professions education. J Allied Health. 2000;29:241-245.
28. Weinrich S. The debate about prostate cancer screening: what nurses need to know. Semin Oncol Nurs. 2001;17:78-84.
29. Coley CM, Barry MJ, Fleming C, Mulley AG. Early detection of prostate cancer. Part I. Prior probability and effectiveness of tests. The American College of Physicians [review]. Ann Intern Med. 1997;126:394-406.
30. Wolf AM, Nasser JF, Wolf AM, Schorling JB. The impact of informed consent on patient interest in prostate-specific antigen screening [comment]. Arch Intern Med. 1996;156:1333-1336.
31. Cantor SB, Spann SJ, Volk RJ, Cardenas MP, Warren MM. Prostate cancer screening: a decision analysis [comment]. J Family Pract. 1995;41:33-41.
32. Albertsen PC, Hanley JA, Fine J. 20-Year outcomes following conservative management of clinically localized prostate cancer. JAMA. 2005;293:2095-2101.
33. Carter BS, Bova GS, Beaty TH, et al. Hereditary prostate cancer: epidemiologic and clinical features [review]. J Urol. 1993;150:797-802.
34. Carter BS, Steinberg GD, Beaty TH, Childs B, Walsh PC. Familial risk factors for prostate cancer [review]. Cancer Surv. 1991;11:5-13.
35. Jacobsen PB, Lamonde LA, Honour M, Kash K, Hudson PB, Pow-Sang J. Relation of family history of prostate cancer to perceived vulnerability and screening behavior. Psychooncology. 2004;13:80-85.
36. Reiss-Starr CA, Weinrich SP, Creanga D, Weinrich M. The association between family history and participation in free prostate cancer screening. Am J Health Stud. 1998;14:95-104.
37. Bock CH, Peyser PA, Gruber SB, Bonnell SE, Tedesco KL, Cooney KA. Prostate cancer early detection practices among men with a family history of disease. Urology. 2003;62:470-475.
38. Miller SM, Diefenbach MA, Kruus LK, Watkins-Bruner D, Hanks GE, Engstrom PF. Psychological and screening profiles of first-degree relatives of prostate cancer patients. J Behav Med. 2001;24:247-258.
39. Cormier L, Reid K, Kwan L, Litwin MS. Screening behavior in brothers and sons of men with prostate cancer. J Urol. 2003;169:1715-1719.
40. Sartor O. Early detection of prostate cancer in African-American men with an increased familial risk of disease. J La State Med Soc. 1996;148:179-185.
41. Powell IJ, Carpten J, Dunston G, et al. African-American heredity prostate cancer study: a model for genetic research. J Natl Med Assoc. 2001;93:120-123.
42. Royal C, Baffoe-Bonnie A, Kittles R, et al. Recruitment experience in the first phase of the African American Hereditary Prostate Cancer (AAHPC) study. Ann Epidemiol. 2000;10(Suppl):77.
43. Reynolds T. Study seeks to clarify genetic basis of prostate cancer in African Americans. J Natl Cancer Inst. 2003;95:1356-1357.
44. Centers for Disease Control. National Health Interview Survey. www.cdc.gov, 2003.
45. SUDAAN. Research Triangle Institute, Research Triangle Park, Cary, NC, 2004.
46. Sirovich BE, Schwartz LM, Woloshin S. Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence? JAMA. 2003;289:1414-1420.